Report Detail
Global Alimta Market Insights, Forecast to 2025
- RnM3153990 |
- 20 March, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
The global Alimta market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Alimta market based on company, product type, end user and key regions.
This report studies the global market size of Alimta in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Alimta in these regions.
This research report categorizes the global Alimta market by top players/brands, region, type and end user. This report also studies the global Alimta market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Eli Lilly
Abbott Healthcare
Cadila Healthcare
Market size by Product
100mg
500mg
Market size by End User
Pleural Mesothelioma
Non-small Cell Lung Cancer
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Alimta market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Alimta market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Alimta companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Alimta submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Alimta are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Alimta market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Alimta Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Alimta Market Size Growth Rate by Product
- 1.4.2 100mg
- 1.4.3 500mg
- 1.5 Market by End User
- 1.5.1 Global Alimta Market Size Growth Rate by End User
- 1.5.2 Pleural Mesothelioma
- 1.5.3 Non-small Cell Lung Cancer
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Alimta Market Size
- 2.1.1 Global Alimta Revenue 2014-2025
- 2.1.2 Global Alimta Sales 2014-2025
- 2.2 Alimta Growth Rate by Regions
- 2.2.1 Global Alimta Sales by Regions
- 2.2.2 Global Alimta Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Alimta Sales by Manufacturers
- 3.1.1 Alimta Sales by Manufacturers
- 3.1.2 Alimta Sales Market Share by Manufacturers
- 3.1.3 Global Alimta Market Concentration Ratio (CR5 and HHI)
- 3.2 Alimta Revenue by Manufacturers
- 3.2.1 Alimta Revenue by Manufacturers (2014-2019)
- 3.2.2 Alimta Revenue Share by Manufacturers (2014-2019)
- 3.3 Alimta Price by Manufacturers
- 3.4 Alimta Manufacturing Base Distribution, Product Types
- 3.4.1 Alimta Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Alimta Product Type
- 3.4.3 Date of International Manufacturers Enter into Alimta Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Alimta Sales by Product
- 4.2 Global Alimta Revenue by Product
- 4.3 Alimta Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Alimta Breakdown Data by End User
6 North America
- 6.1 North America Alimta by Countries
- 6.1.1 North America Alimta Sales by Countries
- 6.1.2 North America Alimta Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Alimta by Product
- 6.3 North America Alimta by End User
7 Europe
- 7.1 Europe Alimta by Countries
- 7.1.1 Europe Alimta Sales by Countries
- 7.1.2 Europe Alimta Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Alimta by Product
- 7.3 Europe Alimta by End User
8 Asia Pacific
- 8.1 Asia Pacific Alimta by Countries
- 8.1.1 Asia Pacific Alimta Sales by Countries
- 8.1.2 Asia Pacific Alimta Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Alimta by Product
- 8.3 Asia Pacific Alimta by End User
9 Central & South America
- 9.1 Central & South America Alimta by Countries
- 9.1.1 Central & South America Alimta Sales by Countries
- 9.1.2 Central & South America Alimta Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Alimta by Product
- 9.3 Central & South America Alimta by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Alimta by Countries
- 10.1.1 Middle East and Africa Alimta Sales by Countries
- 10.1.2 Middle East and Africa Alimta Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Alimta by Product
- 10.3 Middle East and Africa Alimta by End User
11 Company Profiles
- 11.1 Eli Lilly
- 11.1.1 Eli Lilly Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Eli Lilly Alimta Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Eli Lilly Alimta Products Offered
- 11.1.5 Eli Lilly Recent Development
- 11.2 Abbott Healthcare
- 11.2.1 Abbott Healthcare Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Abbott Healthcare Alimta Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Abbott Healthcare Alimta Products Offered
- 11.2.5 Abbott Healthcare Recent Development
- 11.3 Cadila Healthcare
- 11.3.1 Cadila Healthcare Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Cadila Healthcare Alimta Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Cadila Healthcare Alimta Products Offered
- 11.3.5 Cadila Healthcare Recent Development
12 Future Forecast
- 12.1 Alimta Market Forecast by Regions
- 12.1.1 Global Alimta Sales Forecast by Regions 2019-2025
- 12.1.2 Global Alimta Revenue Forecast by Regions 2019-2025
- 12.2 Alimta Market Forecast by Product
- 12.2.1 Global Alimta Sales Forecast by Product 2019-2025
- 12.2.2 Global Alimta Revenue Forecast by Product 2019-2025
- 12.3 Alimta Market Forecast by End User
- 12.4 North America Alimta Forecast
- 12.5 Europe Alimta Forecast
- 12.6 Asia Pacific Alimta Forecast
- 12.7 Central & South America Alimta Forecast
- 12.8 Middle East and Africa Alimta Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Alimta Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Alimta . Industry analysis & Market Report on Alimta is a syndicated market report, published as Global Alimta Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Alimta market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
